论文部分内容阅读
新近越来越多的临床研究资料表明,异常凝血酶原对原发性肝细胞癌(HCC)具有相当的诊断意义。本文采用酶免疫测定法检测1026例各种良恶性疾病患者血浆异常凝血酶原,进一步探讨异常凝血酶原作为 HCC 标志物的应用价值。
Recently, more and more clinical studies have shown that abnormal prothrombin has significant diagnostic value for primary hepatocellular carcinoma (HCC). In this study, we used enzyme immunoassay to detect abnormal plasma prothrombin in 1026 cases of benign and malignant diseases, and further explored the value of abnormal prothrombin as an HCC marker.